Business

RSS Feed for this category

Medical Marijuana Fees May Price Everyone Out (Opinion)

Location: 
Washington, DC
United States
At some point next year, medical marijuana will finally be available to qualifying patients in the District. The problem? It might be too expensive for anyone to grow it or sell it, much less for anyone to actually afford to buy it.
Publication/Source: 
DCist (DC)
URL: 
http://dcist.com/2010/09/dc_medical_marijuana_program_slowly.php

Medical Marijuana Providers Host Washington State’s First Cannabis Farmers Market

Location: 
Conquering Lion
Tacoma, WA
United States
Only those with medical marijuana authorization forms gained entrance to an event billed as the state’s first cannabis farmers market. “These are farmers growing agricultural medicine, so it seemed like a no-brainer,” said Jeremy Miller, organizer and owner of Sacred Plant Medicine. “It’s a place where people can network with other patients in similar situations.”
Publication/Source: 
The News Tribune (WA)
URL: 
http://www.thenewstribune.com/2010/09/20/1349247/medical-pot-providers-stage-farmers.html

Medical Marijuana Growers Join Teamsters Union

Location: 
Oakland, CA
United States
As organized labor faces declining membership, one of the United States' most storied unions is looking to a new growth industry: marijuana.
Publication/Source: 
KGW (OR)
URL: 
http://www.kgw.com/news/business/103285559.html

T-Mobile Hit With Lawsuit for Blocking Marijuana Texts

T-Mobile "did not approve" of a company called EZ Texting, which does business with a website, WeedMaps.com, that provides information on the location of legal medical marijuana dispensaries in California. Today, EZ Texting sued T-Mobile in the U.S. District Court in New York City. EZ Texting says that on Sept. 10th, T-Mobile began "unlawful blocking" of its 313131 text service, which it offers to business and non-profits to help get their message to the public.
Publication/Source: 
DailyFinance (US)
URL: 
http://www.dailyfinance.com/story/media/t-mobile-lawsuit-for-blocking-marijuana-texts/19638589/

Mexico's Drug War Impacts Business

Location: 
Mexico
Mexico became a manufacturing mecca thanks, in part, to its inexpensive labor and proximity to the massive U.S. market. But there is a new reality on the ground in that country these days: a surge in violence tied to the prohibition-based war on drug traffickers that Mexico's President Felipe Calderon mounted after his election in 2006. The result has been a wave of kidnappings, extortion and murder that is threatening the country's economic health and causing multinationals to examine closely how they operate and invest in Mexico.
Publication/Source: 
Latin Business Chronicle (FL)
URL: 
http://www.latinbusinesschronicle.com/app/article.aspx?id=4526

Drug Traffickers Cripple Mexican Oil Operation

Location: 
Mexico
The meandering network of pipes, wells and tankers belonging to the gigantic state oil company Pemex has long been an easy target of crooks and drug traffickers who siphon off natural gas, gasoline and even crude, robbing the Mexican treasury of hundreds of millions of dollars annually. Now the prohibition-created drug traffickers have taken sabotage to a new level: They've hobbled key operations in parts of the Burgos Basin, home to Mexico's biggest natural-gas fields.
Publication/Source: 
Arizona Daily Star (AZ)
URL: 
http://azstarnet.com/news/local/border/article_48a9ef76-1d70-532d-98fe-c83556dd26e6.html

Border Factories Caught in Drug War's Crossfire

Location: 
Mexico
The head of an association of border factory owners said the sector is in crisis mode as unrelenting drug prohibition violence in northern Mexico has spooked investors into curtailing operations at some plants and rethinking expansion at others.
Publication/Source: 
San Antonio Express-News (TX)
URL: 
http://www.mysanantonio.com/news/mexico/border_factories_caught_in_drug_wars_crossfire_102599174.html

Medical Marijuana Growers Worry About Threat From Superstores

Location: 
CA
United States
Oakland is about to become the first city to authorize large scale marijuana cultivation. The move could generate millions of dollars in taxes and create hundreds of new jobs. While the measure has yet to pass, current medical marijuana growers fear the move will drive many of them out of business.
Publication/Source: 
Voice of America (DC)
URL: 
http://www.voanews.com/english/news/economy-and-business/Medical-Marijuana-Growers-Worry-About-Threat-From-Superstores-102385309.html

Germany to Approve Sativex, But Not Medical Marijuana [FEATURE]

German press reports a couple of weeks ago carried headlines saying "Lawmakers Ready to Approve Medical Marijuana" and "Germany Plans to Legalize Medical Marijuana." Those reports were incorrect, and so was the Drug War Chronicle story based on them, "Germany Legalizing Medical Marijuana." (The title to that story, which we have since updated, now reads "Reports of Germany Legalizing Medical Marijuana Are Premature.")

Tetrahydrocannabinol (courtesy wikimedia.org)
According to the International Association for Cannabis as Medicine, whose executive director, Dr. Franco Grotenherman, also heads the German Association for Cannabis as Medicine, what actually happened is that the German government has modified its drug laws to reclassify marijuana from Annex I (no medical use) to Annex II, as long as it is "intended for the productions of preparations for medicinal purposes" -- not raw marijuana.

The health ministry also approved adding "cannabis extract (extract obtained from plants and parts of plants belonging to the species cannabis) in preparations approved as medicines" to Annex III of the drug law. That means that Sativex, a sublingual marijuana extract composed primarily of the compounds Tetrahydrocannabinol (THC) and Cannabidiol, will qualify as medicine under German law, and that its maker, Britain-based GW Pharma, can now apply to market it there.

GW Pharma is partnering with the pharmaceutical giant Bayer in marketing Sativex. Approval to use Sativex in Germany is expected to happen next year. It will only be approved for the treatment of spasticity in multiple sclerosis.

GW Pharma's move in Germany is part of a broader roll-out of Sativex, which has already been approved for limited use in Britain, won preliminary approval in Spain, and this week, was approved for MS spasticity in Canada. The company also plans to seek approvals in other European Union countries, including France and Italy.

"There are media reports that the German government is intending to ease the access to cannabis for medicinal purposes," said Dr. Grotenhermen in response to a Chronicle query. "Most of the reports are misleading. The German government has agreed to allow pharmaceutical companies to apply for approvals on cannabis-based medicines in Germany. No other changes with regard to the medical use of cannabis are intended by the German government. The German Association for Cannabis as Medicine is calling the media reports initiated by the German government 'misleading,' since they suggest that cannabis will be available in Germany soon for many patients, while it is only for spasticity in MS after the approval of Sativex for this indication," Grotenherman said.

"The German government announced a 'major breakthrough' for cannabis as medicine in Germany, and nearly all the newspapers repeated this without knowing what the 'breakthrough' actually was," explained German hemp activist Steffen Geyer. "The next day, the real decision was made public, and it basically said they will change the law so Bayer can sell Sativex to patients with multiple sclerosis. The 'breakthrough' is really a small step, and they aren't doing it for the patients, but for the companies."

Cannabidiol (courtesy Cacycle, wikimedia.org)
And that means no relief in sight for most of Germany's medical marijuana patients.  As things now stand, people in Germany who want to use medical marijuana have two choices: If all other treatment options have been tried already, they can be prescribed Marinol, which is expensive and typically not covered by health insurance. Or, since a German court ruling forced the government's hand, they can apply to the government for special permission to use medical marijuana.

Only about 40 patients are permitted to do so, and they must buy their medical marijuana from a Dutch supplier, Bedrocan, in German pharmacies. They cannot grow their own, and no one can grow it for them, either. Just last month, the Federal Institute for Drugs and Medical Devices rejected a patient's bid to grow his own. The patient had permission to get cannabis at the pharmacy, but said he could not afford it.

"Most patients who tried Marinol said it didn't work like natural cannabis, so after a couple of years, the institute 'invented' an extract made from cannabis flowers and sesame seed oil," said Geyer. "That didn't work, either. It was even worse than Marinol. Again, a couple of years went by, some more patients died, then the court ruling forced the government to allow some patients to use cannabis as medicine. But that Dutch medical marijuana is expensive, so most patients can't afford the amount they actually need. But since, like everybody else, they are not allowed to buy or grow their own, some of them are in jail."

Pharmaceutical Bedrocan goes for $18-30 a gram, while black market marijuana sells for $6-15 a gram, Geyer reported.

"So, none of this changes, and now the wonderful news that Germany will be the next country where Bayer can get richer by selling Sativex," the activist sardonically noted. "But it won't be in the pharmacies, it will only be for specified conditions, you will still have to try all the other therapies first, and health insurance won't pay the bill."

The German government's resistance to expanding access to medical marijuana comes even as opinion polls show strong support for it among the citizenry. An August poll had 76% of German voters in favor of medical marijuana and only 18% opposed. Similarly, 65% said health insurance should pay for it.

Medical marijuana patients and would-be patients need to continue to organize, said Geyer. "We need to get the German patients more political," he said. "For the last 10 years, there was often a gulf between 'good' patients and 'bad' recreational users, and that sucked the political power out of the movement. But patients started to see this as a problem, and have begun to ask hemp activists about advice for political campaigns. This year, for example, for the first time, we had legal patients marching in the Hemp Parade, and that led to widespread news coverage related to cannabis medicine." 

Geyer has a plan. "The next step on my medical cannabis agenda is to get more patients to ask for legal permission to grow their own marijuana," he said. "The cost problem may make that possible. Both Marinol and the Bedrocan are far, far more expensive than the plant, and most patients just don’t have the money. There is a chance this will work soon. After the first couple of 'I Can Grow' patients, I would like to establish a patients' cannabis social club, but that's at least two or three years away."

Germany has allowed corporate cannabis medicine a foot in the door, but it is so far still leaving the vast majority of possible beneficiaries of medical marijuana -- the patients -- on the outside waiting to get in.

Germany

Mapping the Legal Marijuana Industry

Location: 
CA
United States
If California's Proposition 19 passes this Novemeber, plenty of moneymakers will want in.
Publication/Source: 
Forbes.com (NY)
URL: 
http://www.forbes.com/2010/08/17/oaksterdam-legalization-medicine-technology-marijuana.html?boxes=Homepagechannels

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School